CT/NG testing market refers to the market for testing Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections. CT and NG are two of the most common sexually transmitted infections (STIs) globally. Testing for these infections is crucial because they can often be asymptomatic, leading to their spread unknowingly and potentially causing serious health issues if left untreated.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104333528
CT/NG Testing market in terms of revenue was estimated to be worth $1.7 Billion in 2023 and is poised to reach $2.7 Billion by 2028, growing at a CAGR of 8.6% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. Factors such as the rising prevalence of CT/NG infections, growing investments and funds in CT/NG and increasing awareness for CT/NG diagnosis are driving the growth of this market. However, lack of skilled professionals and the high cost of CT/NG testing instruments is likely to hinder the growth of CT/NG testing market.
The CT/NG testing market encompasses various types of diagnostic tests designed to detect the presence of these bacteria. Some common testing methods include nucleic acid amplification tests (NAATs), enzyme immunoassays (EIA), and nucleic acid hybridization tests. These tests can be performed on different types of samples, such as urine, swabs from the genital area, or self-collected vaginal swabs.
Read the full report @ https://www.globenewswire.com/news-release/2023/07/26/2711352/0/en/CT-NG-Testing-Market-is-Expected-to-Reach-2-7-Billion-MarketsandMarkets.html
The market for CT/NG testing has been growing due to several factors:
Rising Prevalence of STIs: Chlamydia and gonorrhea are among the most commonly reported STIs globally. The increasing prevalence of these infections has led to a higher demand for testing services.
Public Health Initiatives: Governments and health organizations have been emphasizing the importance of regular STI testing to control the spread of these infections.
Technological Advancements: Advancements in diagnostic technologies have led to more accurate, rapid, and user-friendly testing methods, which have increased testing accessibility.
Growing Awareness: Increased awareness of STIs and the importance of early detection has encouraged more individuals to seek testing.
Focus on Preventive Healthcare: With a greater emphasis on preventive healthcare, routine STI screening has become a standard part of healthcare for sexually active individuals.
Key Market Players:
The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott Laboratories (US), QIAGEN (Netherlands), PerkinElmer Inc. (US), Bio-Rad Laboratories, Inc. (US), Siemens Healthineers AG (Germany), Danaher (US), Becton, Dickinson and Company (US), Seegene, Inc. (South Korea), Meridian Bioscience Inc. (US), Binx Health, Inc. (US), Visby Medical, Inc. (US), Geneproof A.S. (Czech Republic), Bioneer Corporation (South Korea), Genetic Signatures (Australia), Microbiologics, Inc. (US), Vircell S.L. (Spain), Sansure Biotech Inc. (China), ELITechGroup (France), Molbio Diagnostics Pvt. Ltd. (India), Operon S.A. (Spain), Tianlong Technology Co., Ltd. (China), and Goffin Molecular Technologies B.V. (Netherlands).
North America dominates the global CT/NG testing market
North America holds the largest share and expects to dominate the CT/NG testing market. The large share of North America in this market can be attributed to the increasing prevalence of CT/NG, rising advancements in technology, and the growing healthcare system that is highly developed in the US and Canada.
Buy CT/NG Testing Industry Report (187 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=104333528
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines — TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies — helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1–888–600–6441
Email: [email protected]
